News

Vertex price target lowered to $55 from $60 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Vertex (VERX) to $55 from $60 and keeps an Overweight rating on the shares. The firm is ...
Morgan Stanley Remains a Buy on Vertex (VERX)
In a report released today, Chris Quintero from Morgan Stanley maintained a Buy rating on Vertex (VERX – Research Report), with a price target ...
Yahoo Finance20d
Vertex Announces Program Updates for Type 1 Diabetes Portfolio
Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...